BAX - Baxter's Clinolipid gets FDA approval for use in infants
2024-05-13 12:23:07 ET
More on Baxter
- Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
- Baxter International Inc. 2024 Q1 - Results - Earnings Call Presentation
- Baxter International Inc. (BAX) Q1 2024 Earnings Call Transcript
- Baxter downgraded to hold by TD Cowen in wake of selloff
- Baxter Non-GAAP EPS of $0.65 beats by $0.04, revenue of $3.59B beats by $40M